TABLE 1.
Item | Important (≥4) | Desirable (3.5–3.9) | Not important (<3.5) |
---|---|---|---|
Overall format | Use of traffic light colours
Pamphlet format Carton/thick paper Graphics specific to child versus adult |
Linked to a calendar of symptoms
Coupled with a prescription sheet Referring to inhaler by commercial names and colour Contract wording (using “I”) Copy for patient medical file |
Orientation from top to bottom
One-page format |
General messages and languages | Possibility of living a normal life
Environmental control Nonpharmacological measures Regular medical follow-up Asthma education Adherence Importance of self-management Criteria for asthma control Inhalation technique Treatment of comorbidities Avoidance of smoking |
Recognition of asthma as a chronic disease
Recognition of compliance as a challenge |
|
Asthma control zones | Emphasis on: urgent visit if loss of control; preventive management; and asthma control criteria
Instruction on beta2-agonist use Characteristics of medications |
Treatment of rhinitis or allergic conjunctivitis | Recommendations for nasal hygiene during colds
Emphasis on treatment of flare-ups |
Space for | Additional criteria
Instructions to step-up therapy Other recommendations Recommendation for exposure to asthma triggers |
Environmental recommendations
Phone contact of educator RQAM Web site |
Follow-up appointment date
Phone contact of physician Phone contact of pharmacist Emergency phone contact Phone contact of clinic or hospital Treatment of comorbidities |
Endorsed items were rated for their importance on a Likert scale of 1 (not important) to 5 (very important): items rated 4 or more were considered important for inclusion in the self-management plan; those that averaged 3.5 to 3.9 were considered desirable and were included whenever possible; while items rated lower than 3.5 were considered not important. RQAM Réseau québécois de l’asthme et de la MPOC (Quebec Network of Asthma and COPD)